About StemCell.News | Exosome & Stem Cell News

Who We Are

StemCell.News is the premier digital platform dedicated to Stem Cell News: exosome therapy, stem cell clinical trials, and cutting-edge regenerative medicine.

We provide science-backed insights, regulatory updates, and expert analysis to empower patients, physicians, and biotech innovators.

Our mission is to bridge the gap between research and real-world applications, helping readers navigate the rapidly evolving landscape of stem cell news including stem cell FDA approvals, clinical trials, and breakthrough treatments.

Stem Cell News Coverage

Exosome Therapy: The latest research, clinical applications, and how exosomes are reshaping regenerative medicine.
Stem Cell FDA Approval, Insights & Regulations: Stay updated on the latest rulings, policy changes, and legal considerations in stem cell therapy.
Clinical Trials & Industry News: In-depth coverage of active stem cell and exosome therapy trials worldwide.
Regenerative Medicine Innovations: Insights into PRP, peptides, MSCs, and orthobiologic treatments revolutionizing healthcare.

Why Trust Us? Our articles are backed by leading researchers, industry experts, and peer-reviewed studies to ensure accuracy and credibility.

Meet Lonnie Rae Kurlander: Founder & Industry Expert

Lonnie Rae Kurlander is a biotech entrepreneur, investor, and regulatory expert who has spent years at the forefront of stem cell research, exosome therapy, and regenerative medicine. Featured in leading medical publications, Lonnie provides cutting-edge analysis on exosome therapy, FDA stem cell approvals, and the ethical landscape of regenerative medicine.

Former Chief of Staff to TOBI, Lonnie has worked extensively in biotech innovation, regulatory analysis, and orthobiologics, bridging the gap between cutting-edge research and real-world application.

Lonnie Rae Kurlander keynote as SAP FKOM

A Personal Word:

For years, I’ve been at the intersection of regenerative medicine—both as a patient and a professional. My journey with Ehlers-Danlos Syndrome, Mast Cell Activation Syndrome, and chronic musculoskeletal instability has shaped my deep understanding of the complex realities of stem cell therapy, exosome treatments, and clinical innovation.

As someone who has undergone extensive orthobiologic treatments, navigated complex care pathways, and personally tested the emerging therapies discussed, I’ve developed a firsthand perspective on what works, what doesn’t, and how patients can make the most informed choices.

Beyond my personal experience, I’ve run an active consultancy for years, helping patients refactor and expand their care teams, access the best practitioners, and create individualized treatment plans. While I’ve been privileged to help many, the demand far exceeds what I can offer on a personal level.

That’s why I created StemCell.News...

To address the most common patient questions with real, science-backed answers.
To support regulation, approval pathways, and ethical standards in regenerative medicine.
To dispel myths, cut through misinformation, and elevate evidence-based treatments.
To share my ongoing journey—testing therapies, tracking clinical advancements, and offering deep insights from both a patient and industry perspective.

StemCell.News is meant to be trusted resource, built by someone who has lived this journey, understands the challenges, and believes in empowering others with clear, actionable knowledge.

My mission is simple: To help patients, physicians, and industry leaders navigate the evolving landscape of regenerative medicine—so that together, we can advance safe, effective, and scientifically validated treatments.

Join me as I explore the latest in stem cell research, exosome therapy, and clinical trials—while continuing my own quest for progress, innovation, and truth in regenerative medicine.

Why Stem Cell News is Diferrent

With so much misinformation in the regenerative medicine space,
we cut through the hype by focusing on:

Scientific Accuracy – We analyze clinical data and regulatory updates with an expert perspective.
Unbiased Reporting – We highlight both the promise and risks of regenerative therapies.
Patient & Industry Education – Our goal is to help patients make informed decisions and biotech companies navigate regulatory challenges.

Who We Are

Stem Cell News Coverage

Meet Lonnie Rae Kurlander: Founder & Industry Expert

A Personal Word:

Why Stem Cell News is Diferrent

Follow Us: